MENU
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Biohaven (BHVN) Ownership - Who owns Biohaven?
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.46B
P/E Ratio
N/A
Total Cash
322.75M
Projected Growth
N/A
Total Debt
35.51M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BHVN
Capitalization
1.46B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
323M
Total Cash/Share
3.16
Total Debt
35.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
259M
P/B Ratio
5.64
Cash Flow
N/A
Earnings
-9.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.69B
Current Ratio
2.33
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-914.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-202.53
Shares Held By Institutions
3.55B
Shares Outstanding - Current
102M
Total Liabilities
199M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-61.633
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com